We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

250 hedge funds and large institutions have $510M invested in First Trust NYSE Arca Biotechnology Index Fund in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 62 increasing their positions, 101 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.7% less ownership

Funds ownership: 52.29%50.59% (-1.7%)

7% less funds holding

Funds holding: 269250 (-19)

12% less capital invested

Capital invested by funds: $578M → $510M (-$67.7M)

39% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 101

53% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 30

Holders
250
Holders Change
-19
Holders Change %
-7.06%
% of All Funds
3.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
62
Reduced
101
Closed
30
Calls
$2.82M
Puts
Net Calls
+$2.82M
Net Calls Change
+$475K
Name Holding Trade Value Shares
Change
Change in
Stake
KPWS
51
Kestra Private Wealth Services
Texas
$1.45M +$41.4K +260 +3%
NW
52
NewEdge Wealth
Pennsylvania
$1.4M -$94K -590 -6%
PFS
53
Prospera Financial Services
Texas
$1.4M -$220K -1,381 -14%
First Trust Advisors
54
First Trust Advisors
Illinois
$1.35M +$10.5K +66 +0.8%
Jones Financial Companies
55
Jones Financial Companies
Missouri
$1.33M +$68K +427 +5%
WIA
56
World Investment Advisors
California
$1.31M +$51.5K +323 +4%
CHAM
57
Clear Harbor Asset Management
Connecticut
$1.31M -$79.8K -501 -6%
PSF
58
Pacific Sun Financial
California
$1.31M -$45.4K -285 -3%
MCM
59
MAI Capital Management
Ohio
$1.3M +$95.4K +599 +8%
Baird Financial Group
60
Baird Financial Group
Wisconsin
$1.3M +$146K +916 +13%
MCWS
61
McKinley Carter Wealth Services
West Virginia
$1.19M
Bank of New York Mellon
62
Bank of New York Mellon
New York
$1.18M +$98.1K +616 +9%
BPA
63
Beacon Pointe Advisors
California
$1.14M +$84.1K +528 +8%
PAG
64
Private Advisor Group
New Jersey
$1.11M -$149K -938 -12%
P
65
&Partners
Tennessee
$1.09M +$626K +3,930 +139%
AAS
66
Avantax Advisory Services
Texas
$1.09M +$120K +754 +13%
NRI
67
NFP Retirement Inc
California
$1.08M
SCA
68
Snowden Capital Advisors
New York
$1.01M -$79.2K -497 -7%
GWP
69
Gateway Wealth Partners
Wisconsin
$988K +$17.7K +111 +2%
AF
70
Allworth Financial
California
$967K +$156K +978 +20%
FFA
71
Farther Finance Advisors
California
$961K +$7.65K +48 +0.8%
IWM
72
Iams Wealth Management
Nebraska
$951K +$94.9K +596 +11%
FEG
73
Financial Enhancement Group
Indiana
$943K +$16.7K +105 +2%
HI
74
Harbour Investments
Wisconsin
$930K +$11K +69 +1%
DWP
75
Daymark Wealth Partners
Ohio
$928K +$79.6K +500 +10%

FBT Hedge Fund Activity: Q2 2025 in Review

250 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2025, worth a combined $510M — down 12% from $578M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of FBT and 14 opened new positions — a net loss of 16 holders — while 101 trimmed existing stakes and 62 added.

The largest buyer was Susquehanna International Group, adding an estimated $7.28M. The largest seller was Stonebridge Financial Group (Pennsylvania), exiting entirely with an estimated $13.1M sold.

  • 250 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2025, down from 269 in Q1 2025.
  • Funds reported $510M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2025, down 12% quarter-over-quarter.
  • 14 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2025 and 30 closed out, a net change of -16 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2025 was Susquehanna International Group, an estimated $7.28M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2025 was Stonebridge Financial Group (Pennsylvania), an estimated $13.1M sold.

Based on aggregated 13F filings for Q2 2025.